Oncodesign Société Anonyme announced consolidated earnings results for the full year ended December 31, 2019. For the year, the company reported turnover of EUR 26.91 million against EUR 20.09 million a year ago. Total Operating revenue was EUR 39.51 million against EUR 32.76 million a year ago. Operating income was EUR 0.67 million against operating loss of EUR 3.81 million a year ago. Consolidated net income was EUR 1.62 million against loss of EUR 3.15 million a year ago.

The company is reiterating its 2020 target of €40 million in turnover and positive net income.